Press releases

2012-02-22

Karolinska Development AB (publ) - Year-End Report 2011
2012-02-21

Karolinska Development - Year-End Report, conference call Wednesday, February 22
2012-02-21

Karolinska Development invests in Oss-Q
2012-02-14

KDev Oncology AB invests in GliGene AB
2012-02-13

Karolinska Development announces the formation of KDev Oncology AB - Carl Harald Janson appointed as CEO
2012-02-10

Pergamum completes patient recruitment to the Phase II clinical trial for prevention of post-surgical adhesions
2012-01-16

Pergamum initiates Phase II trial with DPK-060 in outer ear infections
2012-01-09

Akinion Pharmaceuticals initiates Phase I/II clinical trial with AKN-028